Prenetics:因看好鄭志剛旗下網絡而選擇與Artisan合併到美國上市
新世界(00017.HK)執行副主席兼行政總裁鄭志剛旗下的Artisan Acquisition Corp與基因及診斷檢測公司Prenetics合併在美國納斯達克上市,預期交易將於今年底至明年初交割。Prenetics行政總裁兼聯合創辦人楊聖武表示,曾考慮於香港和美國作首次公開發售(IPO),以及與其他特殊目的收購公司(SPAC)合併的方案,最終選擇與Artisan合併是看好鄭志剛旗下網絡,否則可能未必會選擇以SPAC方式上市。
至於未選擇在港上市,他解釋現時在港上市生物科技公司全部來自內地,而Prenetics並未打算在內地發展,因此估值較難作參考。惟他又指,未來會持續審視在香港上市的可能。
他透露,今年首季公司收入達5,700萬美元,預期今年收入將超過2億美元,目標至2025年整體收入達6億美元。Prenetics預測2023至2024年或錄得經營虧損約3,800萬及2,600萬美元,楊聖武指,現時較著重規模增長,又預測至2025年將扭虧,錄經營溢利1,800萬美元。
談及未來發展,他指公司現時在香港及英國有業務,未來計劃拓展至美國及東南亞市場,上市後將運用所得資金收購美國相關檢測發科研公司,投入約3,000萬英磅研發的家居快速檢測系統產品Circle HealthPod,已取得歐洲及英國認證,目標明年首季前獲美國FDA緊急使用審批。
Artisan行政總裁鄭彥斌指,Artisan為長期投資者,重視未來發展過程中的協同效應,Prenetics已與鄭志剛持股的醫思健康(02138.HK)簽署諒解備忘錄,將於今年底在旗下品牌香港各分店銷售產品,另外新世界已訂購約1萬個Circle HealthPod,未來會與更多夥伴拓展合作網絡。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.